Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIX
|
ENSG00000008441.12 | nuclear factor I X |
NFIB
|
ENSG00000147862.10 | nuclear factor I B |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIB | hg19_v2_chr9_-_14313893_14313984 | 0.68 | 1.7e-05 | Click! |
NFIX | hg19_v2_chr19_+_13135790_13135811 | 0.46 | 7.9e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_95360983 | 14.32 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr4_+_111397216 | 11.72 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
chr1_+_171154347 | 10.93 |
ENST00000209929.7
ENST00000441535.1 |
FMO2
|
flavin containing monooxygenase 2 (non-functional) |
chr22_-_36018569 | 10.85 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
chr20_+_43343886 | 10.71 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr16_-_31439735 | 8.71 |
ENST00000287490.4
|
COX6A2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr11_+_77774897 | 7.97 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
chr21_-_31588365 | 7.76 |
ENST00000399899.1
|
CLDN8
|
claudin 8 |
chr20_+_43343476 | 7.55 |
ENST00000372868.2
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr21_-_31588338 | 7.54 |
ENST00000286809.1
|
CLDN8
|
claudin 8 |
chr2_-_217560248 | 7.53 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr9_-_129884902 | 7.53 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
chr3_-_12200851 | 7.45 |
ENST00000287814.4
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
chr2_+_169659121 | 7.19 |
ENST00000397206.2
ENST00000397209.2 ENST00000421711.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
chr1_-_230850043 | 7.17 |
ENST00000366667.4
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
chr12_-_8815215 | 7.01 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr1_-_116311402 | 6.88 |
ENST00000261448.5
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
chr20_+_56136136 | 6.88 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr4_+_41614720 | 6.78 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
chr22_+_38864041 | 6.63 |
ENST00000216014.4
ENST00000409006.3 |
KDELR3
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
chr9_-_129885010 | 6.61 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
chr7_-_99381884 | 6.47 |
ENST00000336411.2
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
chr2_-_151395525 | 6.47 |
ENST00000439275.1
|
RND3
|
Rho family GTPase 3 |
chr12_-_8815299 | 6.35 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr4_+_41614909 | 6.29 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr2_+_169658928 | 6.23 |
ENST00000317647.7
ENST00000445023.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
chr12_-_71003568 | 6.10 |
ENST00000547715.1
ENST00000451516.2 ENST00000538708.1 ENST00000550857.1 ENST00000261266.5 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr15_-_71146480 | 6.06 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr12_+_13061894 | 6.04 |
ENST00000540125.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr20_+_6748311 | 5.96 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
chr19_+_15783879 | 5.88 |
ENST00000551607.1
|
CYP4F12
|
cytochrome P450, family 4, subfamily F, polypeptide 12 |
chr1_-_168698433 | 5.87 |
ENST00000367817.3
|
DPT
|
dermatopontin |
chr1_+_150480576 | 5.83 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr17_-_10452929 | 5.81 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
chr11_+_1944054 | 5.74 |
ENST00000397301.1
ENST00000397304.2 ENST00000446240.1 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
chr1_+_150480551 | 5.72 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr1_+_110009215 | 5.72 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr19_-_17375527 | 5.67 |
ENST00000431146.2
ENST00000594190.1 |
USHBP1
|
Usher syndrome 1C binding protein 1 |
chr5_-_78365437 | 5.57 |
ENST00000380311.4
ENST00000540686.1 ENST00000255189.3 |
DMGDH
|
dimethylglycine dehydrogenase |
chr3_-_46608010 | 5.56 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
chr1_-_201398985 | 5.56 |
ENST00000336092.4
|
TNNI1
|
troponin I type 1 (skeletal, slow) |
chr10_+_115312766 | 5.51 |
ENST00000351270.3
|
HABP2
|
hyaluronan binding protein 2 |
chr1_-_209792111 | 5.47 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
chr1_-_26394114 | 5.45 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
chr2_+_234545148 | 5.38 |
ENST00000373445.1
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10 |
chr2_-_152382500 | 5.37 |
ENST00000434685.1
|
NEB
|
nebulin |
chr12_+_119616447 | 5.32 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr11_-_2170786 | 5.31 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr5_+_42423872 | 5.25 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
chr12_-_9268819 | 5.20 |
ENST00000404455.2
|
A2M
|
alpha-2-macroglobulin |
chr11_-_35547151 | 5.20 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
chr20_+_43343517 | 5.12 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr5_+_147443534 | 5.10 |
ENST00000398454.1
ENST00000359874.3 ENST00000508733.1 ENST00000256084.7 |
SPINK5
|
serine peptidase inhibitor, Kazal type 5 |
chr1_+_153600869 | 5.10 |
ENST00000292169.1
ENST00000368696.3 ENST00000436839.1 |
S100A1
|
S100 calcium binding protein A1 |
chr2_+_234545092 | 5.06 |
ENST00000344644.5
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10 |
chr17_+_41005283 | 5.06 |
ENST00000592999.1
|
AOC3
|
amine oxidase, copper containing 3 |
chr7_+_37960163 | 5.02 |
ENST00000199448.4
ENST00000559325.1 ENST00000423717.1 |
EPDR1
|
ependymin related 1 |
chr4_-_16077741 | 5.02 |
ENST00000447510.2
ENST00000540805.1 ENST00000539194.1 |
PROM1
|
prominin 1 |
chr19_-_45826125 | 4.97 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chrX_+_46937745 | 4.94 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
chr3_-_149293990 | 4.92 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
chr6_+_132129151 | 4.90 |
ENST00000360971.2
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
chr3_+_45067659 | 4.90 |
ENST00000296130.4
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr20_+_36974759 | 4.89 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
chr20_+_44098385 | 4.88 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr11_+_27062502 | 4.83 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr12_+_52626898 | 4.82 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
chr16_+_57406368 | 4.80 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr7_-_99277610 | 4.62 |
ENST00000343703.5
ENST00000222982.4 ENST00000439761.1 ENST00000339843.2 |
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5 |
chr10_-_97200772 | 4.62 |
ENST00000371241.1
ENST00000354106.3 ENST00000371239.1 ENST00000361941.3 ENST00000277982.5 ENST00000371245.3 |
SORBS1
|
sorbin and SH3 domain containing 1 |
chr20_+_44098346 | 4.61 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr3_-_49170405 | 4.57 |
ENST00000305544.4
ENST00000494831.1 |
LAMB2
|
laminin, beta 2 (laminin S) |
chr12_-_15038779 | 4.56 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr10_-_75401500 | 4.55 |
ENST00000359322.4
|
MYOZ1
|
myozenin 1 |
chr1_-_151798546 | 4.54 |
ENST00000356728.6
|
RORC
|
RAR-related orphan receptor C |
chr3_+_148457585 | 4.52 |
ENST00000402260.1
|
AGTR1
|
angiotensin II receptor, type 1 |
chr1_+_233749739 | 4.50 |
ENST00000366621.3
|
KCNK1
|
potassium channel, subfamily K, member 1 |
chr2_-_211179883 | 4.50 |
ENST00000352451.3
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
chr15_+_74466012 | 4.46 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr1_+_209878182 | 4.45 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr1_+_110009150 | 4.38 |
ENST00000401021.3
|
SYPL2
|
synaptophysin-like 2 |
chr3_-_49170522 | 4.35 |
ENST00000418109.1
|
LAMB2
|
laminin, beta 2 (laminin S) |
chr18_+_29171689 | 4.33 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr11_-_107590383 | 4.32 |
ENST00000525934.1
ENST00000531293.1 |
SLN
|
sarcolipin |
chr10_+_88728189 | 4.30 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr15_+_84322827 | 4.27 |
ENST00000286744.5
ENST00000567476.1 |
ADAMTSL3
|
ADAMTS-like 3 |
chr7_+_116165038 | 4.24 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr9_-_95298254 | 4.23 |
ENST00000444490.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr2_+_79347577 | 4.21 |
ENST00000233735.1
|
REG1A
|
regenerating islet-derived 1 alpha |
chr2_+_217498105 | 4.20 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
chr1_+_162351503 | 4.17 |
ENST00000458626.2
|
C1orf226
|
chromosome 1 open reading frame 226 |
chr3_-_50340996 | 4.15 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr4_+_169575875 | 4.14 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
chr5_+_145316120 | 4.13 |
ENST00000359120.4
|
SH3RF2
|
SH3 domain containing ring finger 2 |
chr3_+_8775466 | 4.13 |
ENST00000343849.2
ENST00000397368.2 |
CAV3
|
caveolin 3 |
chr16_-_2004683 | 4.10 |
ENST00000268661.7
|
RPL3L
|
ribosomal protein L3-like |
chr16_-_46797149 | 4.10 |
ENST00000536476.1
|
MYLK3
|
myosin light chain kinase 3 |
chr17_+_37821593 | 4.10 |
ENST00000578283.1
|
TCAP
|
titin-cap |
chr12_-_9268707 | 4.09 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
chr10_+_124221036 | 4.09 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr11_+_12399071 | 4.08 |
ENST00000539723.1
ENST00000550549.1 |
PARVA
|
parvin, alpha |
chr10_+_123970670 | 4.07 |
ENST00000496913.2
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
chr7_+_141490017 | 4.05 |
ENST00000247883.4
|
TAS2R5
|
taste receptor, type 2, member 5 |
chr17_+_4854375 | 4.05 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
chr7_-_99569468 | 4.04 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr11_+_18287721 | 4.01 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr3_-_52488048 | 3.99 |
ENST00000232975.3
|
TNNC1
|
troponin C type 1 (slow) |
chr14_+_95047725 | 3.99 |
ENST00000554760.1
ENST00000554866.1 ENST00000329597.7 ENST00000556775.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr7_-_16844611 | 3.90 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
chr17_+_59477233 | 3.89 |
ENST00000240328.3
|
TBX2
|
T-box 2 |
chr17_-_39769005 | 3.89 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr9_+_6215799 | 3.87 |
ENST00000417746.2
ENST00000456383.2 |
IL33
|
interleukin 33 |
chr4_+_24797085 | 3.86 |
ENST00000382120.3
|
SOD3
|
superoxide dismutase 3, extracellular |
chr3_-_184971853 | 3.86 |
ENST00000231887.3
|
EHHADH
|
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
chr11_+_47608198 | 3.85 |
ENST00000356737.2
ENST00000538490.1 |
FAM180B
|
family with sequence similarity 180, member B |
chr17_+_37784749 | 3.85 |
ENST00000394265.1
ENST00000394267.2 |
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr5_+_78365577 | 3.84 |
ENST00000518666.1
ENST00000521567.1 |
BHMT2
|
betaine--homocysteine S-methyltransferase 2 |
chr8_+_9009296 | 3.82 |
ENST00000521718.1
|
RP11-10A14.4
|
Uncharacterized protein |
chr1_+_86046433 | 3.82 |
ENST00000451137.2
|
CYR61
|
cysteine-rich, angiogenic inducer, 61 |
chr17_-_67224812 | 3.81 |
ENST00000423818.2
|
ABCA10
|
ATP-binding cassette, sub-family A (ABC1), member 10 |
chr16_-_20556492 | 3.79 |
ENST00000568098.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
chr3_-_149688655 | 3.78 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
chr12_+_72667203 | 3.77 |
ENST00000547300.1
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme |
chr3_-_149093499 | 3.77 |
ENST00000472441.1
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr10_-_104597286 | 3.73 |
ENST00000369887.3
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1 |
chr6_-_39902160 | 3.73 |
ENST00000340692.5
|
MOCS1
|
molybdenum cofactor synthesis 1 |
chr3_+_29322437 | 3.73 |
ENST00000434693.2
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr1_-_79472365 | 3.72 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
chr9_-_97356075 | 3.72 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
chr12_-_52911718 | 3.71 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr12_-_91505608 | 3.71 |
ENST00000266718.4
|
LUM
|
lumican |
chr1_+_201159914 | 3.70 |
ENST00000335211.4
ENST00000451870.2 ENST00000295591.8 |
IGFN1
|
immunoglobulin-like and fibronectin type III domain containing 1 |
chr2_+_120187465 | 3.70 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
chr11_+_27062860 | 3.69 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr15_-_35088340 | 3.69 |
ENST00000290378.4
|
ACTC1
|
actin, alpha, cardiac muscle 1 |
chr10_-_93392811 | 3.68 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
chr15_+_96873921 | 3.68 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr12_-_8815404 | 3.67 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr19_-_36247910 | 3.65 |
ENST00000587965.1
ENST00000004982.3 |
HSPB6
|
heat shock protein, alpha-crystallin-related, B6 |
chr6_+_160769399 | 3.64 |
ENST00000392145.1
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
chr1_-_203144941 | 3.61 |
ENST00000255416.4
|
MYBPH
|
myosin binding protein H |
chr3_-_189840223 | 3.61 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
chr5_-_36301984 | 3.60 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
chr11_+_114166536 | 3.60 |
ENST00000299964.3
|
NNMT
|
nicotinamide N-methyltransferase |
chr10_+_99332198 | 3.55 |
ENST00000307518.5
ENST00000298808.5 ENST00000370655.1 |
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
chr11_+_114168773 | 3.55 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
chr1_-_204183071 | 3.52 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
chr11_+_57310114 | 3.49 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr14_+_95047744 | 3.49 |
ENST00000553511.1
ENST00000554633.1 ENST00000555681.1 ENST00000554276.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr1_-_116311323 | 3.49 |
ENST00000456138.2
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
chr7_-_94953878 | 3.48 |
ENST00000222381.3
|
PON1
|
paraoxonase 1 |
chr1_-_22263790 | 3.48 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
chr22_+_24577183 | 3.47 |
ENST00000358321.3
|
SUSD2
|
sushi domain containing 2 |
chr7_-_135433534 | 3.46 |
ENST00000338588.3
|
FAM180A
|
family with sequence similarity 180, member A |
chr1_+_1370903 | 3.46 |
ENST00000338660.5
ENST00000404702.3 ENST00000476993.1 ENST00000471398.1 |
VWA1
|
von Willebrand factor A domain containing 1 |
chr7_-_73038822 | 3.46 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
chr1_+_47533160 | 3.44 |
ENST00000334194.3
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1 |
chr1_+_207277632 | 3.42 |
ENST00000421786.1
|
C4BPA
|
complement component 4 binding protein, alpha |
chr13_+_31480328 | 3.42 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
chr17_-_66951474 | 3.41 |
ENST00000269080.2
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
chr11_+_34654011 | 3.41 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
chr11_+_71903169 | 3.40 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
chr19_+_45281118 | 3.39 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr19_-_42947121 | 3.38 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr15_+_71839566 | 3.38 |
ENST00000357769.4
|
THSD4
|
thrombospondin, type I, domain containing 4 |
chr9_-_114361665 | 3.38 |
ENST00000309195.5
|
PTGR1
|
prostaglandin reductase 1 |
chr3_+_174158732 | 3.36 |
ENST00000434257.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
chr11_+_34642656 | 3.36 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chrX_+_46940254 | 3.35 |
ENST00000336169.3
|
RGN
|
regucalcin |
chr3_+_42727011 | 3.35 |
ENST00000287777.4
|
KLHL40
|
kelch-like family member 40 |
chr13_-_44735393 | 3.34 |
ENST00000400419.1
|
SMIM2
|
small integral membrane protein 2 |
chr7_-_99381798 | 3.34 |
ENST00000415003.1
ENST00000354593.2 |
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
chr1_+_47264711 | 3.33 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr12_+_53443963 | 3.32 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr11_-_119247004 | 3.32 |
ENST00000531070.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr2_-_238499725 | 3.31 |
ENST00000264601.3
|
RAB17
|
RAB17, member RAS oncogene family |
chr1_+_101185290 | 3.31 |
ENST00000370119.4
ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
chr14_-_38725573 | 3.31 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
chr6_-_39197226 | 3.31 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
chr17_+_68100989 | 3.31 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr7_-_73038867 | 3.31 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
chr11_+_75428857 | 3.31 |
ENST00000198801.5
|
MOGAT2
|
monoacylglycerol O-acyltransferase 2 |
chr1_-_27240455 | 3.30 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
chr4_-_88450612 | 3.26 |
ENST00000418378.1
ENST00000282470.6 |
SPARCL1
|
SPARC-like 1 (hevin) |
chr1_-_171621815 | 3.26 |
ENST00000037502.6
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response |
chr14_-_23876801 | 3.22 |
ENST00000356287.3
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha |
chr3_-_184971817 | 3.22 |
ENST00000440662.1
ENST00000456310.1 |
EHHADH
|
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
chr17_-_15168624 | 3.22 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
chr9_+_74764340 | 3.21 |
ENST00000376986.1
ENST00000358399.3 |
GDA
|
guanine deaminase |
chr16_+_57406437 | 3.21 |
ENST00000564948.1
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr11_-_61687739 | 3.20 |
ENST00000531922.1
ENST00000301773.5 |
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
chr1_-_153585539 | 3.17 |
ENST00000368706.4
|
S100A16
|
S100 calcium binding protein A16 |
chr8_-_23712312 | 3.16 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr8_+_92261516 | 3.15 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
chr16_+_55522536 | 3.15 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr3_-_58613323 | 3.15 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
chr10_+_5238793 | 3.14 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
chr11_-_47206965 | 3.14 |
ENST00000525725.1
|
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
chr11_+_18287801 | 3.14 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr9_+_69650263 | 3.10 |
ENST00000322495.3
|
AL445665.1
|
Protein LOC100996643 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.0 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
3.9 | 15.7 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
3.5 | 10.5 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
3.1 | 9.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
3.0 | 8.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
2.7 | 10.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.6 | 5.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.5 | 15.0 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
2.5 | 12.3 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
2.4 | 14.6 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
2.4 | 14.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.3 | 6.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
2.2 | 20.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
2.2 | 11.0 | GO:1904640 | response to methionine(GO:1904640) |
2.1 | 4.3 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
2.1 | 2.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
2.1 | 10.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.1 | 6.2 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
2.0 | 6.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
1.8 | 5.5 | GO:0001300 | chronological cell aging(GO:0001300) |
1.8 | 5.5 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
1.8 | 5.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.8 | 7.1 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
1.7 | 1.7 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
1.7 | 6.7 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.6 | 4.9 | GO:0006147 | guanine catabolic process(GO:0006147) |
1.6 | 6.5 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
1.6 | 4.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
1.6 | 1.6 | GO:0043491 | protein kinase B signaling(GO:0043491) |
1.6 | 7.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.6 | 15.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.6 | 14.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.5 | 4.6 | GO:0097187 | dentinogenesis(GO:0097187) |
1.5 | 9.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
1.5 | 6.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
1.5 | 6.0 | GO:0009956 | radial pattern formation(GO:0009956) |
1.5 | 4.4 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
1.4 | 4.3 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
1.4 | 5.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
1.4 | 1.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.4 | 8.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
1.4 | 1.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.4 | 5.6 | GO:0002933 | lipid hydroxylation(GO:0002933) |
1.4 | 5.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.4 | 4.2 | GO:1901207 | regulation of heart looping(GO:1901207) |
1.4 | 5.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.4 | 8.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.4 | 8.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
1.4 | 2.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
1.4 | 1.4 | GO:0016107 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
1.3 | 9.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.3 | 4.0 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.3 | 9.3 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
1.3 | 9.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.3 | 10.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.2 | 3.7 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
1.2 | 1.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
1.2 | 6.1 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 3.6 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
1.2 | 1.2 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
1.2 | 4.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.1 | 4.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.1 | 6.8 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
1.1 | 5.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
1.1 | 3.4 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.1 | 1.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
1.1 | 1.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
1.1 | 1.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.1 | 4.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
1.1 | 4.4 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
1.1 | 3.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.1 | 14.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.1 | 5.5 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
1.1 | 9.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.1 | 5.4 | GO:0007525 | somatic muscle development(GO:0007525) |
1.1 | 3.2 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
1.1 | 4.3 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.1 | 5.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.1 | 2.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.1 | 5.3 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
1.0 | 3.1 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
1.0 | 4.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
1.0 | 4.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.0 | 11.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.0 | 5.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 4.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.0 | 1.0 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.0 | 5.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.0 | 2.9 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
1.0 | 2.9 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
1.0 | 2.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.0 | 3.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.9 | 2.8 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.9 | 5.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.9 | 6.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.9 | 1.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.9 | 5.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.9 | 6.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.9 | 4.6 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 2.7 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.9 | 1.8 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.9 | 2.7 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.9 | 8.1 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.9 | 2.7 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.9 | 12.4 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.9 | 3.5 | GO:2001250 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.9 | 8.7 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.9 | 3.4 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.8 | 2.5 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.8 | 6.7 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.8 | 3.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.8 | 12.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 4.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.8 | 4.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.8 | 0.8 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.8 | 5.8 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.8 | 8.9 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.8 | 2.4 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.8 | 3.2 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.8 | 1.6 | GO:0048627 | myoblast development(GO:0048627) |
0.8 | 8.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.8 | 6.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.8 | 3.2 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.8 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.8 | 4.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.8 | 1.6 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.8 | 2.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.8 | 9.5 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.8 | 9.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 5.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.8 | 0.8 | GO:1901660 | calcium ion export(GO:1901660) |
0.8 | 3.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 3.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.8 | 6.9 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.8 | 26.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.8 | 6.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.8 | 2.3 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.7 | 2.2 | GO:0090265 | response to high density lipoprotein particle(GO:0055099) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.7 | 12.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.7 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.7 | 3.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.7 | 8.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.7 | 2.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.7 | 3.7 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.7 | 2.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.7 | 8.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.7 | 2.9 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.7 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.7 | 1.4 | GO:0003285 | septum secundum development(GO:0003285) |
0.7 | 5.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 1.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.7 | 1.4 | GO:0055001 | muscle cell development(GO:0055001) |
0.7 | 13.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 3.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 5.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.7 | 2.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 2.1 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.7 | 1.4 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.7 | 1.4 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.7 | 5.5 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.7 | 39.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.7 | 4.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.7 | 0.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.7 | 5.4 | GO:0046618 | drug export(GO:0046618) |
0.7 | 2.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.7 | 9.3 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 1.3 | GO:0060197 | cloacal septation(GO:0060197) |
0.7 | 3.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.6 | 9.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 3.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.6 | 1.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.6 | 1.9 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.6 | 5.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 1.3 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.6 | 2.5 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.6 | 0.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.6 | 1.9 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.6 | 4.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.6 | 5.0 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.6 | 1.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.6 | 5.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 3.1 | GO:1990035 | inorganic cation import into cell(GO:0098659) calcium ion import across plasma membrane(GO:0098703) inorganic ion import into cell(GO:0099587) calcium ion import into cell(GO:1990035) |
0.6 | 0.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.6 | 1.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 3.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.6 | 0.6 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.6 | 1.9 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.6 | 1.9 | GO:0060279 | negative regulation of B cell differentiation(GO:0045578) positive regulation of ovulation(GO:0060279) |
0.6 | 1.9 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.6 | 1.9 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.6 | 1.8 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.6 | 5.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.6 | 7.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 4.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 3.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.6 | 2.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 4.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 3.6 | GO:0097435 | fibril organization(GO:0097435) |
0.6 | 1.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.6 | 19.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.6 | 10.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 0.6 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.6 | 10.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.6 | 10.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.6 | 1.7 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.6 | 2.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.6 | 3.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.6 | 1.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.6 | 2.3 | GO:0060262 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.6 | 6.8 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
0.6 | 1.7 | GO:0048241 | epinephrine transport(GO:0048241) |
0.6 | 9.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 5.6 | GO:1990834 | response to odorant(GO:1990834) |
0.6 | 7.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 3.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.6 | 2.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.6 | 2.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.5 | 6.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.5 | 1.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.5 | 1.6 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.5 | 2.2 | GO:0033685 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.5 | 20.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 2.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.5 | 11.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.5 | 3.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 6.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.5 | 1.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 3.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.5 | 5.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.5 | 6.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.5 | 1.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 2.6 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.5 | 0.5 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.5 | 2.5 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.5 | 2.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.5 | 3.5 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.5 | 3.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 3.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.5 | 3.0 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.5 | 1.5 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) inner ear receptor cell differentiation(GO:0060113) |
0.5 | 1.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 2.0 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.5 | 5.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.5 | 1.5 | GO:0034059 | response to anoxia(GO:0034059) |
0.5 | 0.5 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.5 | 2.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.5 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.5 | 11.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.5 | 6.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 4.3 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.5 | 2.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 5.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.5 | 6.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.5 | 1.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.5 | 8.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.5 | 2.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.5 | 1.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 0.5 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.5 | 7.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.5 | 2.8 | GO:0015853 | adenine transport(GO:0015853) |
0.5 | 1.4 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 5.5 | GO:0060068 | vagina development(GO:0060068) |
0.5 | 1.4 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.5 | 1.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.5 | 3.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 6.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 3.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.5 | 20.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 3.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 23.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 3.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.4 | 1.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 0.4 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.4 | 1.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.4 | 10.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 11.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 11.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 1.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 4.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 5.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 1.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 2.2 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.4 | 2.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 3.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 13.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 3.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 0.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.4 | 4.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.4 | 1.3 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.4 | 2.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 3.4 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 12.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 2.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 2.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 0.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.4 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.4 | 1.6 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.4 | 0.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.4 | 1.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 9.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.4 | 2.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 8.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.4 | 1.6 | GO:0018277 | protein deamination(GO:0018277) |
0.4 | 4.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 2.0 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.4 | 1.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.4 | 1.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 0.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.4 | 1.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.4 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.4 | 1.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.4 | 1.6 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 1.2 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.4 | 2.4 | GO:0006863 | purine nucleobase transport(GO:0006863) nucleobase transport(GO:0015851) |
0.4 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 9.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.4 | 5.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.4 | 1.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.4 | 4.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 1.5 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 1.5 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.4 | 0.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 2.7 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.4 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.4 | 1.5 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 11.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 1.9 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.4 | 5.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.4 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.4 | 0.7 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.4 | 5.1 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.4 | 2.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.4 | 2.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.4 | 6.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 4.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 1.8 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.4 | 1.8 | GO:0015793 | glycerol transport(GO:0015793) |
0.4 | 12.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 1.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 1.4 | GO:0009386 | translational attenuation(GO:0009386) |
0.3 | 8.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.3 | 0.7 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.3 | 1.0 | GO:2000259 | positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 1.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 1.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.3 | 2.4 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.3 | 2.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 1.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 1.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 2.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 3.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 0.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 1.7 | GO:0032571 | response to vitamin K(GO:0032571) |
0.3 | 1.7 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.3 | 1.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 3.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 4.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 2.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.3 | 1.0 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.3 | 4.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 4.6 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 7.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 1.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 11.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 2.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 5.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.3 | 0.3 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.3 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 1.0 | GO:0019516 | lactate oxidation(GO:0019516) |
0.3 | 2.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.3 | 6.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 1.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 1.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 6.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 3.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 1.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 1.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 1.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 6.8 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.3 | 2.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 1.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 3.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.3 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.3 | 0.9 | GO:0008306 | associative learning(GO:0008306) |
0.3 | 0.6 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.3 | 0.3 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 5.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 2.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 2.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 1.1 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
0.3 | 0.3 | GO:0048372 | lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
0.3 | 1.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.3 | 8.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 3.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 2.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 2.2 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.3 | 11.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 1.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.3 | 1.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.3 | 1.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.3 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 0.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 0.8 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.3 | 0.8 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.3 | 1.1 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.3 | 1.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.3 | 0.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.3 | 5.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.8 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 2.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.3 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 2.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 2.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.8 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.3 | 1.6 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 1.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.3 | 3.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 1.3 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.3 | 1.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.3 | 0.8 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.3 | 0.8 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.8 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.3 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 4.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 5.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 2.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 2.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 2.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 9.0 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 2.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.5 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 2.5 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.2 | 0.7 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.2 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 4.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 3.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 1.4 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.2 | 0.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 3.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 11.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 18.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 2.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.9 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.2 | 1.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 4.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.6 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 1.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 1.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.2 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.2 | GO:0016458 | gene silencing(GO:0016458) |
0.2 | 0.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.2 | 0.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 2.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 2.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.2 | 1.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.2 | 1.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 1.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 1.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 2.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 1.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 2.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 1.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.2 | 3.1 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 1.1 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.2 | 0.2 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.4 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.2 | 1.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.8 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 2.6 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 3.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 1.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.4 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.2 | 1.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 1.1 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 0.2 | GO:0046102 | adenosine catabolic process(GO:0006154) hypoxanthine salvage(GO:0043103) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.2 | 1.3 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.2 | 0.9 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 0.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 0.6 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 | 0.2 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.2 | 3.0 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 0.9 | GO:0015918 | sterol transport(GO:0015918) |
0.2 | 3.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 1.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 0.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 2.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 5.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 3.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 6.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 4.2 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.6 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.2 | 0.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.2 | 1.0 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 | 0.6 | GO:0051257 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
0.2 | 2.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 1.0 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 1.4 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 5.3 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 1.4 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.2 | 9.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 2.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 3.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 3.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.6 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.2 | 2.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.8 | GO:0007632 | visual behavior(GO:0007632) visual learning(GO:0008542) |
0.2 | 4.6 | GO:0098743 | cell aggregation(GO:0098743) |
0.2 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.2 | 2.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 5.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 2.8 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 4.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 1.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 5.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 0.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 2.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.2 | 0.4 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.2 | 1.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.4 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.2 | 1.2 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.2 | 1.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 1.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 2.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 2.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.2 | 0.8 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.2 | 1.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.2 | 1.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
0.2 | 2.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 14.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 1.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 2.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.5 | GO:0045008 | depyrimidination(GO:0045008) |
0.2 | 0.5 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.2 | 2.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 2.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 1.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 4.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 1.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.2 | 0.4 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.2 | 1.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 0.7 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.2 | 1.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.2 | 2.3 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.2 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 1.4 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.2 | 4.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 5.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 1.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 1.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.5 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.2 | 1.2 | GO:0001519 | peptide amidation(GO:0001519) peptide modification(GO:0031179) |
0.2 | 4.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 0.7 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.2 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 1.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.2 | 0.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 2.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 2.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 3.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 1.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.8 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 1.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 3.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.2 | 1.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 1.1 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.2 | 0.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 6.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.2 | 0.9 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.2 | 0.6 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.3 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.6 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) negative regulation of activation of membrane attack complex(GO:0001971) |
0.2 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 3.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 3.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.5 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.2 | 4.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 0.3 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.3 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 0.5 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.2 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 5.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 0.8 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.2 | 0.8 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.2 | 1.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.2 | 2.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 1.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.7 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 3.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.1 | 1.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 2.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.3 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 2.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.6 | GO:1905225 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.1 | 0.3 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 1.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 1.8 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 4.0 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 1.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 2.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 2.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 1.4 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.1 | 3.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 1.2 | GO:0061458 | reproductive system development(GO:0061458) |
0.1 | 1.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.7 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 1.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 1.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.5 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 8.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.1 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.7 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 0.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.5 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.1 | 6.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 16.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 1.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 3.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 1.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.6 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 2.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.5 | GO:0001501 | skeletal system development(GO:0001501) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 2.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 5.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.1 | 0.9 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.9 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 0.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.4 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 10.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.4 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 1.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 1.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.8 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 2.3 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.1 | 2.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 3.0 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.5 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 10.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 5.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 1.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.8 | GO:0042440 | pigment metabolic process(GO:0042440) |
0.1 | 1.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 3.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 2.4 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 1.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.9 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 4.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 2.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.8 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 13.7 | GO:0070268 | cornification(GO:0070268) |
0.1 | 1.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 8.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
0.1 | 0.3 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.1 | 0.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.7 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.1 | 0.3 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.1 | 1.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 1.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 1.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 1.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 1.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 3.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.2 | GO:0090189 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.4 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 3.1 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 6.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 1.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 1.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.7 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 2.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 1.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.2 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 2.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 1.8 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 7.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 1.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 1.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 2.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 2.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 2.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.6 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.6 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.5 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 1.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 1.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.1 | 0.5 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
0.1 | 0.5 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.9 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 3.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.5 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.1 | 1.3 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.2 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.4 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.1 | 0.9 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 1.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 2.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 1.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 3.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 1.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 2.4 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 2.6 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.2 | GO:1903988 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 3.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 1.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.6 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 2.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.1 | 0.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 1.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 1.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.1 | 0.8 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.3 | GO:0019062 | virion attachment to host cell(GO:0019062) |
0.1 | 0.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.4 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 1.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 3.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.1 | 1.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.1 | 0.2 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 2.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.6 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 3.1 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.1 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 2.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.3 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.7 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.1 | 0.9 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.7 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.3 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.1 | 0.8 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.2 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.1 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 1.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.1 | 0.6 | GO:0015867 | ADP transport(GO:0015866) ATP transport(GO:0015867) |
0.1 | 0.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 0.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 2.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0048675 | axon extension(GO:0048675) |
0.1 | 1.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 1.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.7 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 1.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.3 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.1 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0042445 | hormone metabolic process(GO:0042445) |
0.1 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 2.8 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:0046545 | development of primary female sexual characteristics(GO:0046545) |
0.1 | 0.2 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.4 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 1.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 1.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 1.1 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.4 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 1.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.4 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.3 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.7 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 1.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.8 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.0 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 1.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 1.6 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.6 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.0 | 0.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.8 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.3 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.3 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.4 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 1.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.3 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.0 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 3.3 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.4 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.5 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 1.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 3.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.4 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.0 | 0.1 | GO:0010138 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 1.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.4 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 1.0 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 4.6 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.0 | 0.2 | GO:0061053 | somite development(GO:0061053) |
0.0 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 15.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.0 | 0.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 1.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.1 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.0 | 0.9 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.0 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.5 | GO:0090278 | negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.0 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 1.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.6 | GO:0018208 | protein peptidyl-prolyl isomerization(GO:0000413) peptidyl-proline modification(GO:0018208) |
0.0 | 0.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.0 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
2.3 | 9.2 | GO:0036027 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
2.1 | 6.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.9 | 5.8 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
1.8 | 29.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
1.8 | 5.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.4 | 22.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.4 | 4.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
1.4 | 35.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.3 | 3.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.3 | 3.8 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.2 | 8.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.2 | 3.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.2 | 7.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
1.2 | 12.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.2 | 4.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 13.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.1 | 6.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.0 | 10.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 4.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.9 | 7.5 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 38.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 29.7 | GO:0032982 | myosin filament(GO:0032982) |
0.9 | 28.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 38.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.8 | 2.5 | GO:0044299 | C-fiber(GO:0044299) |
0.8 | 14.7 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 7.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 5.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 8.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 12.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.7 | 3.4 | GO:0032449 | CBM complex(GO:0032449) |
0.7 | 7.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.7 | 1.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.6 | 3.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.6 | 3.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.6 | 1.9 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 1.9 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.6 | 2.3 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 2.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 1.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.5 | 6.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.5 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 2.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.5 | 4.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 5.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 1.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 2.9 | GO:0031673 | H zone(GO:0031673) |
0.5 | 6.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 4.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.3 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.4 | 3.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 1.3 | GO:1990032 | parallel fiber(GO:1990032) |
0.4 | 7.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 2.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 4.2 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 2.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 13.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 112.8 | GO:0031674 | I band(GO:0031674) |
0.4 | 3.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 20.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 2.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 4.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 3.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 7.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 2.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.3 | 11.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 3.3 | GO:0044305 | calyx of Held(GO:0044305) |
0.3 | 1.3 | GO:0070985 | TFIIK complex(GO:0070985) |
0.3 | 3.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 166.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 0.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.3 | 15.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 4.2 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 3.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 0.3 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.3 | 21.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 2.7 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 5.3 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 1.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 2.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 5.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.2 | 0.7 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.2 | 24.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 18.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 4.2 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 5.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 20.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 5.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.7 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.2 | 1.3 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 1.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.7 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
0.2 | 0.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 1.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.7 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.8 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.8 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 3.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 3.3 | GO:0033643 | host cell part(GO:0033643) |
0.2 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 5.8 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 8.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 4.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 2.8 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.0 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 6.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.9 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.2 | 5.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 2.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 5.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.2 | 1.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.2 | 0.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 3.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 2.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 3.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 0.3 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 13.2 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 3.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 4.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 11.6 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 2.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 1.4 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 6.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 2.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.7 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 1.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 1.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 12.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 2.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 7.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 2.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 3.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 11.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 1.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.7 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.1 | 3.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 28.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.1 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 0.4 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 4.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 82.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.2 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 11.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 2.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 3.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.0 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.8 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 3.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 4.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 4.8 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 6.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 23.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 5.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 4.8 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 2.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 33.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 3.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 10.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 5.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 24.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 1.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 2.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 12.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 5.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 6.6 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.4 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 5.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 5.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 1.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.2 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.6 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 24.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 2.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.9 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 64.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 5.9 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.0 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 1.2 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.0 | 0.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
2.9 | 11.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
2.7 | 8.2 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
2.5 | 7.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
2.5 | 9.8 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
2.3 | 6.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.3 | 6.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
2.2 | 6.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.1 | 2.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.1 | 12.4 | GO:0051373 | FATZ binding(GO:0051373) |
2.0 | 2.0 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.9 | 5.8 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
1.9 | 5.7 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
1.8 | 7.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
1.8 | 7.1 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.7 | 5.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
1.7 | 24.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.7 | 8.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.7 | 15.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.6 | 8.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.6 | 4.9 | GO:0008892 | guanine deaminase activity(GO:0008892) |
1.6 | 7.8 | GO:0070052 | collagen V binding(GO:0070052) |
1.5 | 9.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.4 | 11.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.4 | 5.8 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
1.4 | 5.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.4 | 4.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.4 | 7.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.4 | 1.4 | GO:0047718 | geranylgeranyl reductase activity(GO:0045550) indanol dehydrogenase activity(GO:0047718) |
1.3 | 13.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.3 | 5.3 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
1.3 | 3.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
1.3 | 3.9 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
1.3 | 39.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.3 | 5.0 | GO:0008431 | vitamin E binding(GO:0008431) |
1.2 | 6.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
1.2 | 3.6 | GO:0019115 | benzaldehyde dehydrogenase activity(GO:0019115) |
1.2 | 8.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.2 | 3.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.2 | 1.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
1.1 | 3.4 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
1.1 | 7.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
1.0 | 3.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 3.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.0 | 3.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 3.0 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
1.0 | 4.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.0 | 3.0 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
1.0 | 14.8 | GO:0019841 | retinol binding(GO:0019841) |
1.0 | 4.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 2.9 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
1.0 | 3.8 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.9 | 2.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 3.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.9 | 2.8 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.9 | 4.6 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.9 | 4.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.9 | 7.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 6.4 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.9 | 2.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 3.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.9 | 3.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 6.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.9 | 9.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.9 | 1.8 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.9 | 4.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 3.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.9 | 4.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 23.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.8 | 8.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 2.5 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.8 | 2.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.8 | 5.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 2.5 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.8 | 3.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.8 | 4.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.8 | 0.8 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.8 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 4.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.8 | 7.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.8 | 0.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 2.4 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.8 | 4.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.8 | 2.3 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.8 | 2.3 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.8 | 3.9 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.8 | 2.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 28.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.8 | 4.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.8 | 30.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.7 | 3.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.7 | 3.0 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.7 | 3.0 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.7 | 3.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 5.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 1.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.7 | 3.7 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.7 | 3.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 9.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.7 | 2.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 4.3 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 5.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 8.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.8 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.7 | 2.8 | GO:0017129 | triglyceride binding(GO:0017129) |
0.7 | 4.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 6.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.7 | 4.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.7 | 10.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 2.0 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.7 | 1.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 9.4 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 6.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 2.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.6 | 3.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 3.2 | GO:0010736 | serum response element binding(GO:0010736) |
0.6 | 3.9 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 1.9 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.6 | 2.5 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.6 | 9.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.6 | 19.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 5.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 6.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 3.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.6 | 6.1 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 3.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 10.8 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.6 | 8.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 3.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 1.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.6 | 10.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.6 | 4.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 5.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 2.3 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.6 | 4.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.6 | 1.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.6 | 1.7 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.6 | 8.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 2.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 1.7 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.6 | 2.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 8.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 6.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 2.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.5 | 2.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.5 | 7.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 4.8 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.5 | 8.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.5 | 6.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 1.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.5 | 6.3 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 0.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.5 | 2.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 2.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.5 | 1.5 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.5 | 1.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.5 | 2.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.5 | 2.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 5.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 3.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 9.6 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.5 | 53.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 4.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.5 | 3.3 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.5 | 6.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.5 | 1.9 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.5 | 1.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.5 | 1.9 | GO:0045118 | azole transporter activity(GO:0045118) |
0.5 | 1.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.5 | 1.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 1.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.5 | 2.3 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 0.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.4 | 9.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 8.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 59.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 1.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 2.2 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.4 | 3.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 17.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 3.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.4 | 2.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.4 | 1.7 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.4 | 11.4 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 3.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.4 | 1.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 3.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 8.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 0.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 4.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 6.6 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 2.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.4 | 2.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 2.9 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.4 | 3.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 1.2 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.4 | 8.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.4 | 15.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 1.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 2.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 2.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.4 | 8.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 3.4 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 1.1 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.4 | 10.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 13.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 1.5 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 1.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 6.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 0.4 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.4 | 3.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 1.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.4 | 8.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 12.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 1.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.4 | 1.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.4 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.3 | 1.0 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.3 | 4.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 2.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 5.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 9.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.7 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.3 | 1.0 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.3 | 1.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 3.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 2.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 5.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 3.9 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 2.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.3 | 1.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 8.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 1.6 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.3 | 8.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 2.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.3 | 3.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 2.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 2.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 45.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 0.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 1.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 1.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 12.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 4.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 7.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 3.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 5.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 1.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.3 | 4.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 23.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 9.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 2.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.3 | 2.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 2.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 1.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 2.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 2.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 0.8 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 1.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 0.3 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.3 | 0.8 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 0.8 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.3 | 0.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.3 | 49.7 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 0.8 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.3 | 1.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 6.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.3 | 5.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 0.8 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.3 | 0.8 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.3 | 5.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 6.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 4.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 2.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 0.8 | GO:0015205 | L-ascorbate:sodium symporter activity(GO:0008520) nucleobase transmembrane transporter activity(GO:0015205) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 3.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 0.8 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.3 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 1.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.3 | 2.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.7 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.2 | 0.7 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.2 | 1.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 4.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 5.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.7 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.2 | 1.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 1.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 1.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 1.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 3.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 0.7 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.2 | 0.9 | GO:1990175 | EH domain binding(GO:1990175) |
0.2 | 10.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 4.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 7.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 0.6 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.2 | 1.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 3.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 4.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 16.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.8 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.2 | 0.8 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 1.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.6 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.2 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 2.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 2.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.2 | 2.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.0 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.2 | 1.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.2 | 2.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 4.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 2.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 2.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 4.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.4 | GO:0030305 | heparanase activity(GO:0030305) |
0.2 | 0.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 3.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 3.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 3.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 6.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.7 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.2 | 0.5 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.2 | 3.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 3.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.5 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 1.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.8 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.2 | 1.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 2.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.5 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.2 | 3.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.2 | 1.3 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.2 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.2 | 0.6 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.2 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 0.5 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.2 | 0.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.6 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.3 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.2 | 0.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 2.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 2.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.6 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 1.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 4.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 1.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 6.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 2.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.7 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 9.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.4 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 0.9 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.4 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 14.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 2.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 2.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 6.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 5.8 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.4 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.1 | 2.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 12.0 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 5.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 1.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 2.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 3.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 2.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 10.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.9 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 4.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 2.0 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 2.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.1 | 1.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.1 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.3 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.1 | 0.3 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.1 | 1.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 3.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.1 | 0.4 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 1.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.1 | 1.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.6 | GO:0052846 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.1 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 4.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.7 | GO:0016769 | transaminase activity(GO:0008483) transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 3.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 74.6 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 2.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0004325 | ferrochelatase activity(GO:0004325) |
0.1 | 1.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.2 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 0.6 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.1 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 1.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.1 | 0.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.1 | 1.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 1.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 3.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.3 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 7.8 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 5.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.8 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.1 | 0.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 0.4 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 1.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 2.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.2 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.1 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 6.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 2.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 3.2 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.2 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.1 | 2.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.1 | 3.3 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 0.4 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.4 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 3.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 3.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 2.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.0 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 2.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 1.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 2.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 1.0 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 9.4 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 4.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 1.0 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 1.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.7 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 4.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.8 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 3.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.0 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 2.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.4 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 2.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 21.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 202.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 15.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 6.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 8.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 17.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 132.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 12.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 3.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 15.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 22.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 23.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 14.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 19.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.3 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 7.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 8.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 4.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 3.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 17.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 4.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 14.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 10.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 5.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 9.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 10.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 3.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 9.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 6.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 8.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 9.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 5.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 29.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 16.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 26.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.2 | 35.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 1.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.7 | 11.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.7 | 18.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 12.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 49.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 28.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 17.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 7.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 22.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 15.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 19.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 26.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.5 | 5.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 7.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 15.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 6.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 12.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 35.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 17.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.4 | 5.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.4 | 8.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 6.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 10.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 18.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 7.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 6.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 7.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 1.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 38.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 17.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 12.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 8.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 12.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 7.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 7.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 5.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 12.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 3.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 5.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 8.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 10.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.3 | 7.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 4.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 10.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 9.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 19.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 17.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 4.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 10.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 4.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 5.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 6.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 4.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 4.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 8.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 36.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 6.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 15.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 10.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 4.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 3.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 2.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 5.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 5.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 8.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.7 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 11.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 7.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 7.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 9.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 12.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 4.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 3.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 3.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 4.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 7.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 11.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 2.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.9 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 1.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 1.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 2.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 8.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 1.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 2.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |